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Abstract
The integration of fluorescence and plasmonic properties into one molecule is of importance in developing multifunctional imaging
and therapy nanoprobes. The aim of this research was to evaluate the fluorescent properties and the plasmonic–photothermal,
therapeutic, and radiotherapeutic potential of 177Lu–dendrimer conjugated to folate and bombesin with gold nanoparticles in the
dendritic cavity (177Lu–DenAuNP–folate–bombesin) when it is internalized in T47D breast cancer cells. The intense near-Infrared
(NIR) fluorescence emitted at 825 nm from the conjugate inside cells corroborated the usefulness of DenAuNP–folate–bombesin
for optical imaging. After laser irradiation, the presence of the nanosystem in cells caused a significant increase in the tem-
perature of the medium (46.8C, compared to 39.1C without DenAuNP–folate–bombesin, P < 0.05), resulting in a significant
decrease in cell viability (down to 16.51% + 1.52%) due to the 177Lu–DenAuNP–folate–bombesin plasmonic properties. After
treatment with 177Lu–DenAuNP–folate–bombesin, the T47D cell viability decreased 90% because of the radiation-absorbed
dose (63.16 + 4.20 Gy) delivered inside the cells. The 177Lu–DenAuNP–folate–bombesin nanoprobe internalized in cancer
cells exhibited properties suitable for optical imaging, plasmonic–photothermal therapy, and targeted radiotherapy.
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Introduction
Different-sized gold nanoparticles (AuNPs) can be classified into
molecular luminescent AuNPs (from 0.3 to 2 nm) and conven-
tional plasmonic AuNPs (from 2 to 100 nm).1 Luminescent
AuNPs lack the characteristic surface plasmon resonance (SPR)
due to the limited number of free electrons but can give a broad
range of emissions from visible to near-Infrared (NIR) regions.1
Due to their SPR, AuNPs can be used as localized heat sources for
cancer treatment.2,3 The photothermal conversion effect in
AuNPs is based on the collective oscillations of the electrons
under optical excitation, which provide strong localized heating
when they are irradiated with a laser or exposed to a certain radio-
frequency field.3–5 The localized heating, reaching temperatures
about of 700C around AuNPs, causes irreversible thermal
destruction of cancer tissues.6–8
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The integration of fluorescence and plasmonic properties
into one molecule is of importance in developing multifunc-
tional imaging and therapy nanoprobes.9,10
Lutetium-177 is a b- and g-emitting radionuclide with a
physical half-life of 162 hours (6.73 days). In the field of
nuclear medicine, an in vivo theranostic approach combines
the potential of both diagnosis and therapy in the same target-
ing molecule by labeling with either a diagnostic (eg, 68Ga) or a
suitable therapeutic (eg, 177Lu) radionuclide.11,12
Dendrimers are hyperbranched polymeric structures. Poly-
amidoamine (PAMAM) dendrimers are spherical macromole-
cules composed of repeating PAMAM units which are known
to have high in vivo stability.13,14 Unmodified cationic PAMAM
dendrimers have been shown to be hemolytic, a property that
was associated with their cationic nature. However, the construc-
tion of novel dendrimers with biocompatible components
through the surface modification of commercially available den-
drimers by PEGylation, acetylation, glycosylation, amino acid,
vitamins, and peptide functionalization have solved the safety
problem of dendrimer-based nanotherapeutics.13
Over the last 2 decades, several experimental evidences
have suggested that the gastrin-releasing peptide (GRP) and
other bombesin-like peptides act as growth factors in many
types of cancer.15 Overexpression of GRP receptors (GRPR)
is present in 96% of breast cancer tissues.16 The overexpression
of folate receptor (FR)-a has been confirmed in all clinical
breast cancer subtypes comprised of estrogen receptor (ER)
positive, progesterone receptor (PR) positive, human epidermal
growth factor receptor(HER2) positive, and triple negative
(ER, HER2, PR) tumors.17–19 Therefore, heterobivalent
conjugates of bombesin and folate are expected to improve the
recognition of breast cancer cells positive to FR and GRPR.
The multifunctional theranostic radiopharmaceutical com-
posed of AuNPs (size range: 1.0-2.9 nm) entrapped within the
internal cavities of 177Lu/68Ga-labeled PAMAM and conjugated
with target-specific molecules (bombesin and folate) at the per-
iphery of the dendrimer has been recently synthesized as a poten-
tial optical and nuclear imaging agent for breast tumors as well as
for targeted radiotherapy and plasmonic photothermal therapy.20
Nevertheless, fluorescent and plasmonic properties of radio-
pharmaceuticals based on AuNPs can significantly differ from
those observed in vitro due to the possible AuNP aggregation
inside cells.21,22
The aim of this research was to evaluate the fluorescent
properties and the plasmonic, photothermal, therapeutic, and
radiotherapeutic potential of the 177Lu–DOTA–dendrimer–
AuNP–folate–bombesin (177Lu–DenAuNP–folate–bombesin)
nanoprobe, when it is internalized in T47D breast cancer cells.
Experimental Methods
Preparation of 177Lu–DenAuNP–Folate–Bombesin and
DenAuNP–Folate–Bombesin
In this research, we used a 177Lu–DenAuNP–folate–bombesin
conjugate for which the carboxylate groups of bombesin and
folic acid were covalently conjugated to the free amine groups
of the dendrimer surface.20 Elemental analysis, particle size
distribution, transmission electron microscopy (TEM) analysis,
ultraviolet (UV)-visible (Vis), scanning electron microscopy
and X-ray analysis, infrared and fluorescence spectroscopies,
and radio-HPLC analyses confirmed the dendrimer functiona-
lization with high radiochemical purity (>95%).20 Briefly,
p-SCN-benzyl-DOTA (S-2-[4-Isothiocyanatobenzyl]-1,4,7,10-
tetraazacyclododecane tetraacetic acid; 5.38 mmol, Macrocyc-
lics, Dallas, Texas) was conjugated in aqueous–basic medium
(bicarbonate buffer, 0.2 M, pH 9.5) to the G4-PAMAM-
(NH2)64 dendrimer (0.3 mmol, Sigma-Aldrich Chemical Co,
St Louis, Missouri). The carboxylate groups of Lys1Lys3
(DOTA)-bombesin (0.55 mmol, piChem, Graz, Austria) and
folic acid (2.27 mmol Sigma-Aldrich Chemical Co) were acti-
vated with HATU in DMF/DIPEA and also conjugated to the
terminal amine groups of the PAMAM-G4 dendrimer. The
conjugate was mixed with 1% HAuCl4 followed by the addi-
tion of NaBH4 and purified by ultrafiltration. A 15-mL aliquot
(1.5 mg/mL) of the dendrimer–AuNP–folate–bombesin conju-
gate was diluted with 1 mol/L acetate buffer (35 mL, pH 5),
followed by the addition of 177LuCl3 (20 mL, 40 GBq/mL, >3
TBq/mg, ITG, Germany). The mixture was incubated at 90C
for 30 minutes. Radiochemical purity was >95% determined by
size-exclusion radio-HPLC (ProteinPak 300SW, Waters, 1 mL/
min, injectable grade water). This complex will be referred to
as 177Lu DenAuNP–folate–bombesin.
Since the radioactive material cannot be handled in TEM
and fluorescent spectroscopy equipment, DenAuNP–folate–
bombesin was used in these studies considering that few
177Lu atoms (traces) are present in the 177Lu DenAuNP–
folate–bombesin system (MW* 30 000 g/mol).
Cell Culture
The T47D breast cancer cell line was originally obtained from
the American Type Culture Collection (Atlanta, Georgia). The
cells were routinely cultured at 37C with 5% CO2 and 85%
humidity in Roswell Park Memorial Institute medium (Sigma-
Aldrich Co) supplemented with 10% fetal bovine serum and
antibiotics (100 U/mL penicillin and 100 mg/mL streptomycin).
These cells were selected since previously we have demon-
strated an important uptake of 177Lu–DenAuNP–folate–bom-
besin in T47D, which was significantly inhibited by
preincubation with cold Lys3-bombesin peptide or folic acid
alone, indicating that the multifunctional system has specific
recognition for GRPRs and FRs.20
Transmission Electron Microscopy
Transmission electron microscopy analyses were performed in
order to corroborate the internalization of DenAuNP–folate–
bombesin in T47D cells. Cells (5  105) were seeded into
6-well plates (Cyto-One, USA Scientific, Ocala, Florida) for
24 hours to allow adherence. DenAuNP–folate–bombesin was
added to cells followed by 1 hour of incubation at 37C. The
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cells were washed 3 times with PBS, centrifuged into small
pellets, and fixed with 2% glutaraldehyde and 2% paraformal-
dehyde in sodium cacodylate buffer (0.1 mol/L). The cells were
further fixed with 1% osmium tetraoxide in 5 mmol/L
2-mercaptoethanol (phosphate–mercaptoethanol buffer),
dehydrated in graded acetone series, and embedded in Epon-
Spurr epoxy resin. Sections were cut at 85 nm using a diamond
knife (Diatome, Hatfield Pennsylvania). The sections were
stained with Sato’s triple lead stain and 5% aqueous uranyl
acetate for organelle visualization. The prepared samples were
examined on a JEOL 1400 TEM microscope (JEOL, Peabody,
Massachusetts) operating at 80 kV.
Fluorescence Imaging of DenAuNP–Folate–Bombesin
Inside Cells
T47D cells (2  103) were grown on glass coverslips and fol-
lowing treatment with dendrimer (Den), Den-AuNP, and
DenAuNP–folate–bombesin were rinsed with ice-cold PBS,
fixed in acetone, and washed twice with PBS. After the addition
of 250 mL (1 mg/mL) of Hoechst (DNA stain), cells were incu-
bated for 1 minute at room temperature and rinsed with PBS
before being mounted onto slides (ProLong Gold; Molecular
Probes, Invitrogen Life Technologies, California). Hereinafter,
the preparation of DenAuNP–folate–bombesin internalized in
the T47D cells will be referred to as DenAuNP–folate–bombesin
cell. Images of the fluorescent AuNPs of DenAuNP cell and
DenAuNP–folate–bombesin cell were taken using an epifluor-
escent microscope (MeijiTechno MT6200; Saitama, Japan).
Hoechst dye inside the nuclei was visualized with an excitation
filter of 330 to 385 nm and using an emission filter of 420 nm.
The AuNPs were detected using an excitation filter of 530 to 550
nm and an emission filter of 590 nm.
X-Ray Photoelectron Spectroscopy)
X-ray photoelectron spectra were acquired on a Thermo
K-Alpha spectrometer equipped with an Al Ka X-ray source
(1486.68 eV). The source was calibrated using Au 4f7/2
(84.0 eV) and Ag 3d5/2 (368.2 eV) from foil samples. An argon
ion beam was used for charge compensation in the samples.
The of DenAuNP–folate–bombesin and DenAuNP–folate–
bombesin cell samples were introduced into an ultrahigh
vacuum chamber of the spectrometer (1  107 to 1  108
Pascal) and measured at 297 K. The spot size in the beam was
200 mm. Twenty scans for Au4f were performed with an energy
step size of 0.03 eV. Survey spectra were measured in the range
of 0 to 1320 eV for DenAuNP–folate–bombesin (Supplemental
Figure S1) and DenAuNP–folate–bombesin cell samples. The
binding energies were referenced to the C1s peak at 285 eV.
Shirley background subtraction was applied to all spectra.
High-resolution spectrum was obtained for Au4f, C1s, and
O1s bands. The Au4f spectrum was statistically analyzed using
the Origin 8.1 software. The best fit was achieved for 4 peaks
with a multipeak model and the Gaussian function with a cor-
relation factor R2 of .987 (DenAuNP–folate–bombesin), and
for 6 peaks and the Lorentzian function with R2 ¼ .994 for the
DenAuNP–folate–bombesin cell.
Fluorescence Spectroscopy Analysis of DenAuNP–Folate–
Bombesin Inside Cells
Emission fluorescence spectra at 291 K of (1) DenAuNP–folate–
bombesin cell sample, (2) T47D cells þ Hoechst (matrix
emission), and (3) T47D cell samples were recorded on a
Perkin-Elmer LS-55 low-resolution luminescence spectrometer,
from 200 to 900 nm (PerkinElmer, Inc., Santa Clara, California).
All the samples were excited with wavelengths in the UV region
to VIS region in order to distinguish between emission bands
from the DenAuNP–folate–bombesin cell and those from the
cells and remaining Hoechst dye themselves and to identify
bands from Raleigh and Raman scatterings of the excitation
lights used as well as harmonics bands in the VIS region from
emission bands in the UV region (see Supplemental material).
The best results for the 3 samples were obtained using excitation
wavelengths (lexc) of 222, 270, 300, and 510 nm; emission filter
of 290, 390, 430, and 515 nm, and excitation; and emission slits
of 5 nm and 50 nm/min. To confirm some emission bands, exci-
tation slit equals to 7 nm and emission slit equals to 10 nm were
also tested. The source parameters were delay time (ms): 10, gate
time (ms): 20, cycle time (ms): 33, and flash time: 3.
Phothothermal Plasmonic Potential of DenAuNP–Folate–
Bombesin Inside Cells
T47D cells were incubated in a 96-well plate at a density of 5 103
cells/well. The cells were cultured for 24 hours at 37C with 5%
CO2 and 85% humidity. Then, the culture medium was removed,
the well plate was placed in a dry block heater at 37C, and the cells
were exposed to one of the following treatments (n¼ 6): (1) 100mL
of Den–folate–bombesin and 100mL of PBS, pH 7 with irradiation
(1.19 W/cm2); (2) 100 mL of DenAuNP–folate–bombesin and 100
mL of PBS pH 7 with irradiation (1.19 W/cm2); (3) 100 mL of
distilled water (without nanoparticles) and 100 mL of PBS pH 7
with irradiation (1.19 W/cm2); or (4) no treatment.
Laser irradiation in all experiments was conducted using a
compact pulsed Nd: YAG laser (Q Smart 100; Quantel laser)
pulsed for 5 ns at 532 nm (energy ¼ 50 mJ/pulse) with a
repetition rate of 10 Hz. The per-pulse laser power was mea-
sured using a Dual-Channel Joulemeter/Power Meter (Molec-
tron EPM 2000; Coherent, Santa Clara, California). A
diverging lens was used in the path of the laser beam such that
the well plate was fully covered by the laser (diameter ¼ 7 mm,
area ¼ 0.38 cm2). The irradiance at the well plate was then
calculated as the laser power per pulse divided by the laser spot
area. Irradiation was performed for 6 minutes while delivering
1.19 W/cm2 of average irradiance.
During laser irradiation, the temperature increase was mea-
sured using a type K thermocouple (model TPK-01) of imme-
diate reaction that had been previously calibrated (probe
diameter ¼ 0.8 mm). The thermocouple was introduced into
the well, and the temperature was registered each second using
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a cold-junction-compensated K-thermocouple to digital con-
verter (MAX6675, Maxim Integrated Products, Inc., San Jose,
California) connected to a microcontroller board (Arduino
Uno, Arduino AG Trademarks) with Universal Serial Bus
(USB) computer connection. After irradiation, the solution of
each well was removed and replaced with fresh medium.
The percentage of surviving cells in each well was evaluated
by the spectrophotometric measurement of cell viability as a
function of mitochondrial dehydrogenase activity, which
involves the cleavage of the tetrazolium ring of sodium 30-(1-
[phenylaminocarbonyl]-3,4-tetrazolium)-bis(4-methoxy-6-
nitro) benzene sulfonic acid hydrate (XTT) in viable cells to
yield orange formazan crystals that are dissolved in acidified
isopropanol (XTT kit, Roche Diagnostics GmbH, Mannheim,
Germany). The resulting absorbance of the orange solution was
measured at 480 nm in a microplate absorbance reader (Epoch,
BioTek, Vermont). The absorbance of the untreated cells was
considered as 100% of T47D cell viability.
Radiotherapeutic Potential: Cell Dosimetry
T47D cells were incubated in a 96-well plate at a density of 5 103
cells/well for 24 hours at 37C with 5% CO2 and 85% humidity.
Then, the culture medium was removed, and the cells were exposed
for 2 hours (at 37C, with 5%CO2 and 85% humidity) to one of the
following treatments (n¼ 6): (1) 100 mL of 177LuCl3 (74 kBq) and
100mL of PBS, pH 7; (2) 100mL of 177Lu–DenAuNP (74 kBq) and
100 mL of PBS, pH 7; (3) 100 mL of 177Lu–DenAuNP–folate–
bombesin (74 kBq) and 100 mL of PBS, pH 7; or (4) no treatment.
After 2 hours, the solution in each well was removed and
replaced with fresh culture medium. The cells were maintained
for 3 days at 37C with 5% CO2 and 85% humidity. After that,
the percentage of cell viability in each well was evaluated using
the XTT kit method, as described earlier. The absorbance of the
untreated cells was considered as 100% of T47D cell viability.
The calculation of absorbed dose in the cell was carried out
by the Committee on Medical Internal Radiation Dose (MIRD)
methodology using the cell internalization factors for 177Lu–
DenAuNP–folate–bombesine and 177Lu–DenAuNP previously
reported by Mendoza-Nava et al.20 The internalized activity is
considered the initial activity A0. From the calculation of the
total number of disintegrations during 3 days and the cell geo-
metric factor (determined by Montecarlo using PENELOPE),
the absorbed dose was computed.
Statistical Analysis
Comparisons between groups in laser irradiation and 177Lu
irradiation studies were made using the student t test (signifi-
cance was defined as P < 0.05).
Results and Discussion
Transmission Electron Microscopy
Figure 1 shows that DenAuNP–folate–bombesin is internalized
in T47D cells and exhibits vacuoles in the cell cytoplasm
(Figure 1, top 3 panels) and on the cell membrane (Figure 1,
bottom 2 panels). This specific recognition and internalization
into the cell cytoplasm is attributed to the biological behavior
conferred by bombesin and folate on the dendrimer surface
which binds to GRPR and FR on the cell membrane.20,23
X-Ray Photoelectron Spectroscopy
The X-ray photoelectron spectroscopy (XPS) spectra of Au4f
core orbitals of the DenAuNP–folate–bombesin system (Figure
2A) revealed 4 peaks corresponding to 2 doublets of the 4f7/2
and Au4f5/2 orbitals of gold, which are shifted to larger binding
energies with respect to those of the bulk gold metal (Au0
atoms), 84.0 and 87.6 eV, (3.67 separation), respectively. The
separation of the first doublets was 3.7 eV and the second one
was of 3.8 eV. Au4f7/2 peaks at 84.3 and 84.6 eV (shifted 0.3
and 0.6 eV) with Full-Width Half-Maximum (FWHM) ¼ 0.8
eV, and Au4f5/2 at 88.0 and 88.4 eV (shifted 0.4 and 0.8 eV)
with FWHM ¼ 1 eV, indicating that in the DenAuNP–folate–
bombesin system, the encapsulated AuNPs are interacting with
the amides and amines of the dendritic cavity with different
degrees of strength because of the AuNP sizes that are between
2.1 and 2.9 nm20 and the coexistence of Au0 and any oxidized
form. The treatment of the XPS spectrum and the extent of the
shift suggest the presence of the AuNPs with the shorter dia-
meter and/or the Au1þ oxidation state in the surface in about
20%. The shift of core Au4f electron peaks is inversely propor-
tional to the grain size.24 In AuNP-S-derivatives, where sulfur
atoms are covalently bonded to AuNPs, the peak of Au1þ
shifted significantly between 0.8 and 2.0 eV with respect to
the Au0 peak position. The coexistence of Au0 and Au1þ atoms
in the encapsulated AuNPs (diameter 2.5 + 0.4 nm), and the
stabilization that the conjugated dendrimer affords to the sys-
tem, explain the particular fluorescence–plasmonic properties
observed in the studied samples.
DenAuNP–folate–bombesin cell sample presented a partic-
ular XPS spectrum (Figure 2B). The positions of the peaks
indicate the presence of 4 defined Au peaks centered at 82.3,
85.2, 89.6, and 94.2 eV, but the multipeak model using the
Lorentzian function revealed 2 additional peaks on the left side
(88.0 eV) and right side (90.6 eV) of the peak at 89.6 eV. The
large shifts with respect to DenAuNP–folate–bombesin defi-
nitely point to a strong interaction of the conjugate system with
the cells, which demonstrate that the conjugate was interna-
lized in the cell, where it is not homogenously distributed and
then exposed to different types of interaction with the cell. The
4f7/2 peak is located at 85.2 eV and 4f5/2 at 89.6 eV which has
been associated with Au1þ with shifts of 0.9 and 1.6 eV with
respect to the conjugate system before contact with the cell.
This shift can also be due to the interaction of the encapsulated
AuNPs with the amine and amide groups of cell proteins. How-
ever, the 4f5/2 peak is the most intense and broader than the
4f7/2 peak because of the contribution of the 2 peaks found by
the fitting. This is an anomaly, since usually the 4f5/2 is less
intense than the 4f7/2 peak. The band at 88.00 eV is associated
with Au0, but the other one seems to be an oxidized form of Au.
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The band at 82.3 eV is too low in energy to correspond to Au0
and that at 94.2 eV is too high for Au1þ oxidation states. This
brings us to propose that once the DenAuNP–folate–bombesin
is inside the cell, several interactions of the conjugate with
anion and cation-transport cellular processes occur, which
leads to chemical changes in the surface of the encapsulated
AuNPs. Gold can have less common oxidation states such as
1, þ2, and þ5. Therefore, it would be possible that Au0
atoms could be reduced to Au1 atoms (auride anion), which
is relatively stable due to the very high Pauling electronegativ-
ity of gold, and its ability to form salts with Ca, K, Cs, and Rb25
and be oxidized to oxidation states higher than Au1þ ions
(possibly 2þ and 3þ oxidation state). The presence of remain-
ing Au0 atoms and electrons from the Au1 atoms on the sur-
face of the encapsulated AuNPs (diameter 2.5 + 0.4 nm) did
not allow the plasmonic resonance band to extinguish in the
DenAuNP–folate–bombesin cell sample.
Fluorescence Spectroscopy
The analysis of spectra recorded under different excitation
wavelengths and emission filters allowed the discarding of
emission bands from the cells and Hoechst dye, excitation light
scatterings, and harmonic bands in the VIS-NIR region (which
are broad usually) from the emission band in the UV region.
In Figure 3, the fluorescence emission spectrum of the
DenAuNP–folate–bombesin cell (Figure 3A) is presented com-
parative to that of the DenAuNP–folate–bombesin conjugate
(Figure 3B) obtained under the same experimental conditions.
Regardless of the extent of the intensities, the intensity ratio of
the UV/VIS-NIR bands of Figure 3A changed with respect to
that of Figure 3B, and bands enveloped in the spectrum of the
latter are revealed in the former. From 200 to 500 nm, the
emission bands correspond to the organic components such
as the functionalized dendrimer, the cells, and the Hoechst dye.
Main bands in the VIS-NIR region (525-900 nm) of Figure 3B
are clearly revealed in Figure 3A although slightly shifted. This
points to the interaction of the DenAuNP–folate–bombesin
with the cell. However, a sharp intense band at 825 nm is
revealed. This lead to search of the origin of such a band. It
was found that this band does not correspond to any scattered
excitation light nor to first harmonic bands from the emission
bands of the sample (for this test, the emission slit was larger
than the excitation slit, Supplemental Figure S2), since it is
present in the DenAuNP–folate–bombesin cell sample at the
same position (+2 nm) for all experimental conditions
Figure 1. Transmission electron microscope (TEM) micrographs. Top panels: intracellular uptake in T47D breast tumor cells treated with
DenAuNP–folate–bombesin for 2 hours. Bottom panels: DenAuNP–folate–bombesin in membrane showing a vacuole formation.
Mendoza-Nava et al 5
(Figure 3A and 4 and Supplemental Figure S2). It was seen as a
poor band in the T47D cells and Hoechst dye spectra, and the
relationship between them is probably that imines, imide, or
imidazole groups are present in proteins and dyes such as
Hoechst. The DenAuNP–folate–bombesin cell spectrum reveals
more pronounced bands in the VIS (valence state effect) and
NIR (surface ligand effect) regions than the DenAuNP–folate–
bombesin, which indicates its internalization in T47D cells.
In Figure 4, the fluorescence emission spectra in the VIS-
NIR region (525-900 nm) excited at 510 nm and with variable
emission filters of (1) DenAuNP–folate–bombesin cell sample,
(2) T47D cells þ Hoechst, and (3) Hoechst are presented. The
spectra from 200 to 900 nm are given in Supplemental Figures
S3 and S4. In the spectra of the 3 samples (Figure S3 and S4), a
shoulder at about 461 nm is observed, which corresponds to the
fluorescence emission of the Hoechst dye. However, this emis-
sion is not the origin of the sharp band observed at 825 nm
because the Stokes shift would be too large for any energy
transfer and neither corresponds to a harmonic band, since
these would appear beyond 900 nm. Figure 4 reveals an
enhanced luminescence in the NIR region with a 515 nm emis-
sion filter, and the sharp band at 825 was the most intense at
this condition. The emission filters did not diminish intensity in
the (1) DenAuNP–folate–bombesin cell sample but disap-
peared in the (2) T47D cells þ Hoechst sample, and it was
negligible in the (3) Hoechst sample. The results demonstrated
that DenAuNP–folate–bombesin was internalized in the cell
and that the encapsulated stabilized AuNP of the DenAuNP–
folate–bombesin system transfers its emission energy to a
excited emission level already present in a component of the
T47D cell proteins (receptors), where it is harvested and then
reemitted with greater intensity. The emission bands from the
DenAuNP–folate–bombesin system between 650 and 770 nm
can act as an energy emission donor. However, in the T47D
cells, the energy emission acceptor is the defined sharp band at
825 nm since being of low intensity became the most intense
band excited at 510 nm with a 515-nm emission filter (Figure
4B) and excited at 222 nm with a 290-nm emission filter (Fig-
ure 3A). The enhanced emission fluorescence spectra of the
DenAuNP–folate–bombesin cell sample under 2 extreme exci-
tation light sources and those emission filters demonstrate that
DenAuNP–folate–bombesin acts as a whole in the cells. The
Stokes shifts between the bands in the 650 to 770 nm interval
and that at 825 nm would be from 55 to 175 nm and point to a
FRET mechanism in the energy transfer of DenAuNP–folate–
bombesin to T47D cells (Fo¨rster resonance energy or fluores-
cence resonance energy transfer,26–28 since the emission bands
of DenAuNP–folate–bombesin are poorly shifted (1-3 nm) and
the typical Fo¨rster distance for FRET (Ro ¼ 1-100 nm) had to
be fulfilled in DenAuNP–folate–bombesin cell.
Figure 2. High-resolution X-ray photoelectron spectroscopy (XPS)
spectra of the Au4f core orbitals of (A) DenAuNP–folate–bombesin
and (B) DenAuNP–folate–bombesin cell.
Figure 3. Fluorescence emission spectra of (A) DenAuNP–folate–
bombesin cell, (B) DenAuNP–folate–bombesin. Excitation wave-
length: 222 nm, filter 290 nm. Excitation and emission slits: 5 nm.
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Small luminescent AuNPs (1.5-3.0 nm) can emit in the VIS
region (valence state effect) and in the NIR region (surface
ligand effect). This is the case of the DenAuNP–folate–bom-
besin, where the encapsulated AuNP has a diameter size
between 2.1 and 2.9 nm.20 The optical properties of the AuNPs
are enhanced by their encapsulation in such a functionalized
dendrimer because of the conformation and stabilization
afforded by the macromolecule whose dendritic cavity inter-
acts with AuNP through the tertiary amines and secondary
amides. As a result of this interaction, about 16% of Au0 atoms
are oxidized to Au1þ atoms (see the X-Ray Photoelectron
Spectroscopy section), and the resulting luminescence (fluor-
escence) is significant; the rest are Au0 atoms (enough electron
charge density), which is the main reason why the SPR band is
still seen as a defined shoulder in the UV/VIS absorption spec-
trum but shifted to higher energy (approximately 510-515 nm)
because of the small size of the AuNPs. It has been demon-
strated that the SPR band of AuNP typically observed at
520 nm shifts to lower or higher energy in an inversely propor-
tional mode to nanoparticle size.29 In fact, it has been reported
that an entrapped AuNP in a functionalized Dendrimer.G5
(Au-TOS-FA-DENPs) with AuNP size of 3.3 nm enhanced its
luminescence and maintained its SPR at 520 nm.30 Every day,
new theoretical and experimental evidences appear, which
demonstrate that AuNPs of diameters sizes between 1.5 and
4 nm are luminescent, that the SPR does not disappear, and that
those with larger size where the SPR effect predominates also
present luminescence. Although the fluorescence–plasmonic
properties of AuNPs are dominated by the valence states of
gold atoms and their particle sizes, it is clear from the above-
mentioned evidence that the type and extent of their chemical
environments can modify photophysical properties of AuNP
systems significantly.
Fluorescence Imaging
Fluorescence images corroborate TEM results, demonstrating
that DenAuNP–folate–bombesin is internalized in the cell. In
this figure, the fluorescence of the nanoconjugate is seen as
bright red dots that are localized either in the nuclei or in the
cytoplasm of the cell.
The fluorescence spectra of DenAuNP–folate–bombesin
cell sample (Figure 4) reveal emissions in the near-infrared
region when it is excited at 510 and 222 nm. The emission
bands between 650 and 850 nm regions are responsible for the
visualization of the nanoparticles in the fluorescence imaging
(Figure 5), under the recording conditions employed.
Effect of Laser Irradiation on Cell Viability
Figure 6 shows that the presence of AuNPs in the dendrimer
significantly increased the temperature of the medium after
laser irradiation (46.8C, compared to 39.1C without AuNPs
within the dendrimer, P < 0.05). As expected, the increase in
temperature of Den–folate–bombesin was similar to the control
Figure 4. A, Fluorescence emission spectra in the visible (VIS)-near-
Infrared (NIR) region of DenAuNP–folate–bombesin cell sample;
Hoechst dye in cells (short dotted line) and Hoechst dye (dotted line).
Excitation wavelength: 510 nm. Emission filter: 290 nm. B, Fluores-
cence emission spectra in the VIS-NIR region of DenAuNP–folate–
bombesin cell sample. Hoechst dye in cells (short dotted line) and
Hoechst dye (dotted line). Excitation wavelength: 510 nm. Emission
filter: 515 nm.
Figure 5. A representative microscopic field (40) of T47D cells (A)
in phase contrast, (B) the Hoechst stained nucleus, (C) the DenAuNP–
folate–bombesin emission after 530 nm excitation, and (D) the
merged nuclear and AuNP fluorescence images.
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sample (PBS), which indicates that changes in temperature are
only determined by the presence of AuNPs within the dendri-
mer in the medium.
The effect of the temperature increase (plasmonic photo-
thermal potential) in the studied treatments after laser irradia-
tion is shown in Figure 6.
The DenAuNP–folate–bombesin system caused a signifi-
cant decrease in cell viability (P < 0.05) down to 16.51% +
1.52% by the end of treatment (6 minutes) when compared to
Den–folate–bombesin (80.1%+ 2.28%; Figure 7). This result
corroborated that the release of heat due to the nanoparticle (the
expected temperature around each nanoparticle is 700C) in
the cytoplasm and the nucleus of T47D cells is the reason for
the significant reduction in cell viability and not just the tem-
perature increase in the medium during those few minutes.
Several trials have demonstrated a significant improvement
in the clinical outcome when radiotherapy was conducted
under hyperthermic conditions in patients. Hyperthermia
increases the efficacy of radiotherapy by improving tumor oxy-
genation and interfering with the DNA repair mechanisms.
However, the current techniques for hyperthermia induction
display low spatial selectivity in the tissues heated. Lasers have
been used to induce hyperthermia, and spatial selectivity can be
improved by adding AuNPs within the dendrimer to the tissue
to be treated. By exposing nanoparticles within the dendrimer
to laser irradiation, it is possible to heat a localized area in the
targeted cell without any harmful heating to the surrounding
healthy tissues. The previous studies using AuNP for
hyperthermia have demonstrated that the functionalization of
AuNPs with probe molecules improves the particle accumula-
tion in cell models significantly.7,8 In this study, we have
demonstrated that the system DenAuNP–folate–bombesin
significantly reduces T47D breast cancer cell viability in com-
parison with Den–folate–bombesin after laser irradiation.
Radiotherapeutic Potential
As shown in Figure 8, the 3 studied treatments reduced the
T47D cell viability, being significantly inhibited by 177Lu–
DenAuNP–folate–bombesin (P < 0.05). This effect is attribu-
table to the greater T47D cell internalization of b-particles due
to the folate and bombesin moiety. 177Lu–DenAuNP does not
affect cell viability as much as 177Lu–DenAuNP–folate–bom-
besin but is higher than 177LuCl3.
177Lu–DenAuNP can be
internalized in the cell by passive endocytosis, whereas
177LuCl3 should not undergo cell internalization.
Figure 7. Effect on viability of T47D cells incubated on the presence
of Den–folate–bombesin, DenAuNP–folate–bombesin, and the con-
trol after laser heating (irradiance 1.1926 W/cm2). *Statistically sig-
nificant difference (P < 0.05) versus DenAuNP–folate–bombesin.Figure 6. Medium temperature increase after laser irradiation of
T47D cells incubated on the presence of Den–folate–bombesin,
DenAuNP–folate–bombesin, and a control solution (irradiance:
1.1926 W/cm2).
Figure 8. Effect of the radiation dose of 177LuCl3,
177Lu–DenAuNP,
and 177Lu–DenAuNP–folate–bombesin on T47D cell viability.
*Statistically significant difference (P < 0.05) versus 177Lu–DenAuNP–
folate–bombesin.
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The results of the cell viability (Figure 8) indicate that
177Lu–DenAuNP–folate–bombesin is about 4 times more lethal
than 177Lu–DenAuNP. This experimental value is in accor-
dance with the theoretical calculation of the absorbed
dose shown in Table 1, where the absorbed dose of 177Lu–
DenAuNP–folate–bombesin is 4 times greater than that of
177Lu–DenAuNP.
For absorbed dose calculation (Table 1), in each treatment,
an activity of 14.8 Bq/cell (74 kBq/5000 cells) was used and the
percentage of cell internalization of approximately 41% (6.07
Bq/cell) for 177Lu–DenAuNP–folate–bombesin and 9.8% (1.45
Bq/cell) for 177Lu–DenAuNP was considered as reported by
Mendoza-Nava et al, with the consequent delivery of a thera-
peutic dose. The factor 4:1 obtained from the internalization
fraction between 177Lu–DenAuNP–folate–bombesin and
177Lu–DenAuNP is in accordance with the lethality factor
(4:1) and with the absorbed dose calculation (4:1).
Conclusion
The 177Lu–DenAuNP–folate–bombesin nanosystem interna-
lized in cancer cells exhibited properties suitable for optical
imaging, plasmonic-photothermal therapy and targeted
radiotherapy.
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